A Multicentre, Randomized Phase III Study of Thalidomide Maintenance Treatment in Patients With Diffuse Large B-cell Lymphoma
Phase of Trial: Phase III
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Thalidomide (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 26 Jul 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 26 Jul 2017 Status changed from not yet recruiting to recruiting.
- 12 Jan 2017 New trial record